Investment House LLC Gilead Sciences, Inc. Transaction History

Investment House LLC

$1.83 Billion
Q3 2024

A detailed history of Investment House LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Investment House LLC holds 17,047 shares of GILD stock, worth $1.56 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

17,047

Previous 17,297 1.45%

Holding current value

$1.56 Million

Previous $1.19 Million 20.4%

% of portfolio

0.08%

Previous 0.07%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$66.59 - $83.99 $16,647 - $20,997	-250 Reduced 1.45%	17,047 $1.43 Million
Q2 2024 Jul 22, 2024	SELL	$63.15 - $72.88 $31,575 - $36,440	-500 Reduced 2.81%	17,297 $1.19 Million
Q3 2023 Nov 09, 2023	SELL	$73.94 - $80.67 $22,182 - $24,201	-300 Reduced 1.66%	17,797 $1.33 Million
Q2 2023 Aug 08, 2023	SELL	$76.01 - $86.7 $30,404 - $34,680	-400 Reduced 2.16%	18,097 $1.39 Million
Q3 2022 Oct 31, 2022	SELL	$59.54 - $68.01 $5,954 - $6,801	-100 Reduced 0.54%	18,497 $1.14 Million
Q2 2022 Aug 09, 2022	SELL	$57.72 - $65.01 $8,658 - $9,751	-150 Reduced 0.8%	18,597 $1.15 Million
Q1 2022 Apr 14, 2022	SELL	$57.92 - $72.58 $252,241 - $316,085	-4,355 Reduced 18.85%	18,747 $1.12 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $554,381 - $598,115	-8,190 Reduced 26.17%	23,102 $1.61 Million
Q2 2021 Jul 20, 2021	BUY	$63.47 - $69.35 $152,328 - $166,440	2,400 Added 8.31%	31,292 $2.15 Million
Q1 2021 May 06, 2021	BUY	$60.0 - $68.46 $12,000 - $13,691	200 Added 0.7%	28,892 $1.87 Million
Q4 2020 Jan 13, 2021	SELL	$56.65 - $64.55 $39,655 - $45,185	-700 Reduced 2.38%	28,692 $1.67 Million
Q3 2020 Nov 06, 2020	SELL	$62.1 - $78.08 $46,575 - $58,560	-750 Reduced 2.49%	29,392 $1.86 Million
Q1 2020 Apr 08, 2020	SELL	$62.63 - $80.22 $70,959 - $90,889	-1,133 Reduced 3.62%	30,142 $2.25 Million
Q4 2019 Feb 05, 2020	SELL	$61.62 - $67.78 $102,165 - $112,379	-1,658 Reduced 5.03%	31,275 $2.03 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $217,097 - $239,637	-3,473 Reduced 9.54%	32,933 $2.09 Million
Q2 2019 Aug 05, 2019	BUY	$61.87 - $69.38 $190,312 - $213,412	3,076 Added 9.23%	36,406 $2.46 Million
Q1 2019 May 03, 2019	SELL	$62.53 - $70.05 $187,902 - $210,500	-3,005 Reduced 8.27%	33,330 $2.17 Million
Q4 2018 Feb 06, 2019	SELL	$60.54 - $79.0 $943,697 - $1.23 Million	-15,588 Reduced 30.02%	36,335 $2.27 Million
Q3 2018 Oct 09, 2018	SELL	$71.28 - $78.92 $955,508 - $1.06 Million	-13,405 Reduced 20.52%	51,923 $4.01 Million
Q2 2018 Jul 10, 2018	SELL	$64.88 - $75.68 $228,701 - $266,772	-3,525 Reduced 5.12%	65,328 $4.63 Million
Q1 2018 May 08, 2018	SELL	$72.84 - $88.8 $79,177 - $96,525	-1,087 Reduced 1.55%	68,853 $5.19 Million
Q4 2017 Jan 31, 2018	SELL	$71.15 - $83.52 $100,677 - $118,180	-1,415 Reduced 1.98%	69,940 $5.01 Million
Q3 2017 Oct 30, 2017	BUY	$72.11 - $85.47 $5.15 Million - $6.1 Million	71,355	71,355 $5.78 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment House LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investment House LLC with notifications on news.

Account

Investment House LLC Gilead Sciences, Inc. Transaction History